AnPac Bio-Medical Science... (ANPC)
NASDAQ: ANPC
· Real-Time Price · USD
4.30
-0.14 (-3.15%)
At close: May 19, 2023, 9:59 PM
AnPac Bio-Medical Science Balance Sheet Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 5, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | n/a | 1.87M | 7.58M | 6.89M | 462K | 9.25M | 5.46M | 8.58M | 9.02M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 1.08M | 855K | 836K | 742K | 923K | 803K | 670K | 805K |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | 2.06M | 459K | 459K | 466K |
Receivables | n/a | 5.54M | 10.77M | 7.52M | 4.57M | 5.55M | 8.09M | 26.64M | 8.22M |
Inventory | n/a | 210K | 384K | 432K | 424K | 490K | 347K | 451K | 972K |
Other Current Assets | n/a | 6.08M | 3.39M | 3.16M | 4.49M | 8.25M | 8.42M | 5.04M | 15.09M |
Total Current Assets | n/a | 13.7M | 37.02M | 31.53M | 16.98M | 23.55M | 22.32M | 40.71M | 33.3M |
Property-Plant & Equipment | n/a | 24.39M | 27.28M | 27.54M | 27.93M | 20.26M | 20.36M | 19.47M | 19.18M |
Goodwill & Intangibles | n/a | 1.3M | 1.33M | 1.24M | 22.32M | 22.75M | 29.61M | 7.67M | 7.88M |
Total Long-Term Assets | n/a | 26.77M | 29.46M | 29.61M | 50.99M | 43.94M | 51.23M | 28.26M | 28.33M |
Total Assets | n/a | 40.47M | 66.48M | 61.15M | 67.97M | 67.49M | 73.55M | 68.97M | 61.63M |
Account Payables | n/a | 2.11M | 5.3M | 3.31M | 3.72M | 2.73M | 1.68M | 1.21M | 687K |
Deferred Revenue | n/a | 4.96M | 4.41M | 4.56M | 4.17M | 4.17M | 4.81M | 5.09M | 4.04M |
Short-Term Debt | n/a | 5.8M | 1.07M | 6.94M | 11.45M | 33.76M | 30.01M | 11.67M | 22.38M |
Other Current Liabilities | n/a | 29.41M | 45.36M | 22.11M | 24.35M | 22.24M | 27.35M | 28.34M | 22.61M |
Total Current Liabilities | n/a | 42.28M | 56.15M | 36.92M | 43.69M | 62.91M | 63.84M | 46.31M | 49.72M |
Long-Term Debt | n/a | 6.51M | 7.75M | 7.53M | 7.38M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 1.08M | 1.09M | 1.09M | 1.1M | 1.11M | 1.11M | 1.12M | 2.04M |
Total Long-Term Liabilities | n/a | 7.59M | 8.84M | 8.62M | 10.55M | 3.27M | 4.34M | 2.12M | 3.06M |
Total Liabilities | n/a | 49.87M | 64.99M | 45.55M | 54.23M | 66.17M | 68.19M | 48.44M | 52.78M |
Total Debt | n/a | 12.31M | 8.82M | 14.47M | 18.83M | 33.76M | 30.01M | 11.67M | 22.38M |
Common Stock | n/a | 5.73M | 2.73M | 2.66M | 1.74M | 1.28M | 1.18M | 1.06M | 1M |
Retained Earnings | n/a | -577.54M | -545.63M | -523.72M | -490.29M | -475.65M | -444.54M | -413.99M | -385.98M |
Comprehensive Income | n/a | 4.26M | 3.05M | 4.37M | 4.91M | 4.53M | 4.63M | 4.26M | 3.19M |
Shareholders Equity | n/a | -13.68M | -3.34M | 10.52M | 8.18M | -4.5M | -322K | 20.86M | 8.74M |
Total Investments | n/a | 1.08M | 855K | 836K | 742K | 923K | 803K | 670K | 805K |